Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.81 and traded as low as $1.95. Aemetis shares last traded at $2.00, with a volume of 688,056 shares traded.
Analyst Ratings Changes
Several research analysts have commented on AMTX shares. StockNews.com upgraded shares of Aemetis to a "sell" rating in a report on Wednesday, February 5th. HC Wainwright restated a "buy" rating and issued a $28.00 price objective on shares of Aemetis in a report on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $12.95.
Read Our Latest Research Report on AMTX
Aemetis Stock Performance
The stock's 50-day moving average price is $2.58 and its two-hundred day moving average price is $2.78. The stock has a market capitalization of $104.86 million, a PE ratio of -0.91 and a beta of 1.44.
Institutional Trading of Aemetis
Hedge funds and other institutional investors have recently modified their holdings of the business. Geode Capital Management LLC grew its position in shares of Aemetis by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company's stock worth $2,126,000 after buying an additional 66,031 shares during the period. State Street Corp grew its position in Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company's stock valued at $1,608,000 after purchasing an additional 185,304 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Aemetis during the 4th quarter valued at about $87,000. Barclays PLC grew its position in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock valued at $109,000 after purchasing an additional 34,816 shares during the last quarter. Finally, Wellington Management Group LLP purchased a new stake in Aemetis during the 3rd quarter valued at about $177,000. 27.02% of the stock is owned by hedge funds and other institutional investors.
About Aemetis
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Stories
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
